Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs

Addiction Research and Theory

Volumn 18, Issue 5, 2010, Pages 544-556

  Fraser, Suzanne ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

addiction; biological citizenship; hepatitis C; Medicalisation

Indexed keywords

EID: 77956224104     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066350903497551     Document Type: Article

References (23)

1. Ballard K, Elston MA. 2005. Medicalisation: A multidimensional concept. Social Theory & Health 3:228-241.
2. Brook H, Stringer R. 2005. Users, using, used: A beginner's guide to deconstructing drugs discourse. International Journal of Drug Policy 16(5):316-325.
3. Brownscombe J. 2004. The uppers and downers of medicalising addiction. Student BMJ 12:89-132.
4. Conrad P, Schneider AW. 1980. Deviance and medicalisation: From badness to sickness. 1st ed. St Louis: Mosby.
5. Duffin J. 2005. Lovers and livers: Disease concepts in history. Toronto: University of Toronto Press.
6. Flyvbjerg B. 2006. Five misunderstandings about case-study research. Qualitative Inquiry 12:219-245.
7. Fraser S. 2004. 'It's your life!': Injecting drug users, individual responsibility and hepatitis C prevention. Health 8(2):199-221.
8. Fried M. 2002. Side effects of therapy of hepatitis C and their management. Hepatology 36(5):S237-S244.
9. Hopwood M, Treloar C. 2005. The experience of interferon-based treatments for hepatitis C infection. Qualitative Health Research 15(5):635-646.
10. Lupton D. 1997. Foucault and the medicalisation critique. In: Petersen A, Bunton R, editors. Foucault, health and medicine. London and New York: Routledge. pp 94-110.
11. Moore D, Fraser S. 2006. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine 62:3035-3047.
12. National Centre in HIV Epidemiology and Clinical Research. 2005. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report. Sydney: NCHECR, UNSW.
13. Orsini M. 2002. The politics of naming, blaming and claiming: HIV, hepatitis C and the emergence of blood tainted activism in Canada. Canadian Journal of Political Science 35(3):475-498.
14. Porter R. 1997. The greatest benefit to mankind: A medical history of humanity. London: Harper Collins.
15. Roberts C, Valentine K, Fraser S. 2009. Rationalities and non-rationalities in clinical encounters. Living drugs, special issue of Science as Culture 18(2):165-181.
16. Rose N. 2007a. The politics of life itself. Princeton: Princeton University Press.
17. Rose N. 2007b. Beyond medicalisation. Lancet 369(9562):700-702.
18. St John T, Sandt L. 2005. The hepatitis C crisis. Ethnicity and Disease 15(S2):52-57.
19. Stoové MA, Gifford SM, Dore GJ. 2005. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence 77:81-86.
20. Tomes N. 2007. Patient empowerment and the dilemmas of late-modern medicalisation. Lancet 369(9562): 698-700.
21. Turner BS. 1995. Medical power and social knowledge. 2nd ed. London: Sage.
22. White WL. 1998. Slaying the dragon: The history of addiction treatment and recovery in America. Bloomington, IL: Chestnut Health Systems.
23. White WL. 2001. Addiction disease concept: Advocates and critics. Counselor, February Retrieved from http:// www.bhrm.org/papers/Counselor3.pdf.